Just as we’re becoming comfortable with the massive changes in cannabis legalization there enters a disruptive new technology called “Cannabinoid Biosynthesis” that has prompted a lot of interest among industry insiders. Here to tell us more about it is Jason Poulos of Librede, a synthetic biology company and leader in cannabinoid biosynthesis based in Southern California. Learn more at https://www.librede.com  Key Takeaways:  Jason’s background in biology and how it led him into the cannabis space A deep dive into cannabinoid biosynthesis and how it’s disrupting the industry An inside look at Librede and how the company has taken the lead in cannabinoid biosynthesis The intricate work involved in designing a molecular drug that efficiently binds with its target Exciting new discoveries surrounding the potential of cannabinoids beyond CBD and THC The importance of CB1 and CB2 receptors and how they interact The relationship between synthetic cannabinoids and cannabinoids found in nature and how Jason believes that relationship will grow Ways in which we could misuse synthetic cannabinoids that we need to avoid Where Jason sees the cannabinoid biosynthesis business heading in the next 3-5 years and how it will affect the cannabis industry    

Ep 270 - Synthetic Cannabinoids Are Opening Up A New World Of Possibilities

Matthew Kind from the website CannaInsider provides weekly interviews with the leading voices of the rapidly growing Cannabis, Marijuana Industry. Listen in and learn as visionaries discuss the trends and technology that are shaping the industry. Each week you’ll learn about; what is going on in The Marijuana Industry, what states are legalizing and when, what jobs are being created by both recreational and Medical Marijuana (MMJ) legalization, ways to invest in cannabis businesses, and fun and safe ways to partake in Marijuana Tourism. Looking for more? We also interview various experts including: cannabis chemists, dispensary owners, manufacturers of marijuana infused products (MIPS), seed companies, marijuana and cannabis investors and entrepreneurs.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Governments around the world tell us we need to simply accept inflation and the destruction of the purchasing power of our money, today's guest shows why deflation, not inflation, is the key to an abundant future in both your cannabis business and your personal life. Listen in as Jeff shares how surging the trends are shaping our lives are accelerating.


Here to tell us is Jeff Booth, author of The Price of Tomorrow.
Jeff’s book: https://www.amazon.com/Price-Tomorrow-Deflation-Abundant-Future/dp/1999257405
Jeff’s Twitter: https://twitter.com/JeffBooth
Key Takeaways:

 Goods and services that are inflationary versus those that are deflationary
 What a deflation economy looks like and examples of when we’ve seen deflation in the past
  The natural deflationary process that’s occurring right now thanks to advancing technologies like AI
  The deceptive power of exponential technologies and how they gain traction
  How central bankers are fighting a losing battle by taking on more debt to create inflation
  The power of network effects for business owners, investors, and employees
  Where Jeff sees bitcoin heading in the next few years and his advice for those looking to get in
  Why Jeff believes AI will eventually force us to embrace deflation and how that could benefit society as a whole


New Trends Affecting Cannabis, Technology, and Culture with Jeff Booth

Is it better to produce your own cannabis products? Or outsource to expert manufacturers while you focus on your brand? Here to tell us is Alex Rowland, CEO of NewTropic.
Learn more at https://www.newtropic.com
Key Takeaways:
[00:51] An inside look at NewTropic, a leading cannabis manufacturer based in Santa Rosa, California
[1:18] Alex’s background in cannabis and how he came to start NewTropic
[5:56] Examples of NewTopic’s average clientele – particularly unlicensed brands looking to overcome California’s strict regulatory hurdles
[7:47] How NewTropic helps relieve two of the biggest pain points for cannabis companies: financial resources and compliance
[17:05] Why removing the regulatory overhead of fulfillment allows companies to focus their attention on core competencies
[18:45] NewTropic’s extensive onboarding process and how the company’s team works to ensure all your needs are met as a client
[20:30] Alex’s plans to expand NewTropic across the US
[25:21] The requirements a company needs to meet before working with NewTropic
[30:16] Alex’s advice to new entrepreneurs on how to develop a successful business plan and pitch to investors
[33:11] Alex’s thoughts on the federal rescheduling of cannabis and where he sees the industry heading in the next few years

How Contract Manufacturers Can Scale Your Cannabis Product

If you hand most people a cannabis drink, their first question is probably, “How high will this make me?”
This one unknown might just be what’s holding cannabis beverages back. Until now.
Listen in as Luke Anderson of Cann discusses the state of cannabis drinks and where he sees the category heading.
Learn more at http://www.drinkcann.com/
Key Takeaways:

 Luke’s background in cannabis and how he came to start Cann
 An inside look at Cann and its mission to become the standard for cannabis-infused tonics
  Why Cann produces only low-THC tonics to target consumers that don’t wish to experience a high
  The type of effect consumers can expect from Cann’s social tonics
  Why Luke believes it’s important to take out the guesswork in cannabis beverages
  Cann’s social tonics versus beer and wine in terms of time and effect
  How Cann decided on its unique THC/CBD concentration profile
  How Luke and his team overcame challenges with emulsion and dispersion to ensure consistency in every sip
  Where Luke sees cannabis microdosing heading in the next few years


These Low-THC Cannabis Drinks Are Disrupting The Alcohol Industry

While thousands of new cannabis products hit the market each year, most fail to create product-market fit due to a lack of differentiation or clear-cut benefits.
Today’s guest is CEO of Dosist Gunner Winston, who has simplified cannabis consumption with targeted formulas and precise dosing to create a product that is catapulting cannabis into the wellness arena.
Learn more at https://dosist.com
Key Takeaways:

 Gunner’s background in cannabis and how he came to start Dosist
 An inside look at Dosist and its mission to simplify cannabis consumption with innovative delivery devices
  How taking the guesswork out of cannabis is attracting more people to the category
  Variables that are important to luxury brand consumers
  Customer reactions to Dosist’s new dose pen and dose dial
  The thought process behind Dosist’s high-end yet minimalist retail environment
  Why Gunner believes brick and mortar stores remain valuable in the age of online shopping
  Where Dosist is in the capital-raising process
  How Gunner is planning to evolve Dosist in the coming years as consumer preferences change


This Dose-Controlled Device Is Launching Cannabis Into the Wellness Arena

Is speed paramount when it comes to a good cannabis delivery service?
Not according to Sava founder Andrea Brooks, who joins us to share how she’s gained more customer satisfaction and larger order sizes than her much faster competitors.
Learn more at https://www.getsava.com
Key Takeaways:

 Andrea’s background in cannabis and how she came to start Sava
 An inside look at Sava and its mission to provide the highest quality cannabis products for delivery in the San Francisco Bay Area
  How Andrea won the AVG Best Pitch Award and what about her presentation resonated most with investors
  What investors need to know about unit economics and basket size
  Common obstacles in cannabis delivery and how Sava has overcome these to get ahead of other services like Ease and MedMen
  Ways in which Sava has gained so many repeat customers
  Sava’s generous compensation for drivers and how this impacts the company’s overall success
  Where Andreas sees the cannabis drink category heading in the next few years
  Andrea’s conservative approach to growth projections and meeting investor expectations
  Where Sava currently is in the capital-raising process and Andrea’s goals for the years ahead


Ep 270 - Synthetic Cannabinoids Are Opening Up A New World Of Possibilities

Download our free app to listen on your phone